Cabaletta Bio, Inc.

NASDAQ:CABA

1.63 (USD) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 000004.0100000000000000000000000
Cost of Revenue 00.46800.4260.3930.3360.3550.83302.8640.3630.2380.2190.2340.2210.1620.116000000000000
Gross Profit 000-0.426-0.3933.674-0.355-0.8330-2.864-0.363-0.238-0.219-0.234-0.221-0.162-0.116000000000000
Gross Profit Ratio 000000.91600000000000000000000000
Reseach & Development Expenses 29.01825.53226.2923.42721.95417.40513.78711.79712.43512.48.2169.5149.179.9198.1697.856.5565.7755.655.3314.623.0263.222.6642.7611.2392.5890.320.32
General & Administrative Expenses 8.1188.2536.7566.8526.0775.7414.8814.0934.5213.9023.5623.5463.8293.9743.3943.2953.1563.5552.7662.8613.2752.8341.8111.1381.2290.8260.4910.2050.205
Selling & Marketing Expenses 00.39300-0.393-0.33600000000000000000000000
SG&A 8.1188.2536.7566.8525.6845.4054.8814.0934.5213.9023.5623.5463.8293.9743.3943.2953.1563.5552.7662.8613.2752.8341.8111.1381.2290.8260.4910.2050.205
Other Expenses 00000000000000000000000000-6.24400
Operating Expenses 37.13633.78533.04630.27927.63822.8118.66815.8916.95616.30211.77813.0612.99913.89311.56311.1459.7129.338.4168.1927.8955.865.0313.8023.992.0653.080.5240.524
Operating Income -37.136-33.785-33.046-30.279-28.031-23.146-18.668-15.89-16.956-16.302-11.778-13.06-12.999-13.893-11.563-11.145-9.712-9.33-8.416-8.192-7.895-5.86-5.031-3.802-3.99-2.065-3.08-0.524-0.524
Operating Income Ratio 00000-5.77200000000000000000000000
Total Other Income Expenses Net 1.1931.1992.4172.6772.9842.262.221.4031.1020.610.3510.150.0530.0050.0030.0060.010.0210.0230.040.410.4570.3810.4440.4580.16-6.1960.0140.014
Income Before Tax -35.943-32.586-30.629-27.602-25.047-20.886-16.448-14.487-15.854-15.692-11.427-12.91-12.946-13.888-11.56-11.139-9.702-9.309-8.393-8.152-7.485-5.403-4.65-3.358-3.532-1.905-9.276-0.51-0.51
Income Before Tax Ratio 00000-5.20800000000000000000000000
Income Tax Expense 0-0.35000.351.457-0.3550.2480-0.813-0.351-0.15-0.053-0.234000-0.11000-0.05100-3.99-2.065-3.1280.0140.014
Net Income -35.943-32.586-30.629-27.602-25.047-20.886-16.448-14.487-15.854-14.879-11.076-12.76-12.893-13.888-11.56-11.139-9.702-9.309-8.393-8.152-7.485-5.403-4.65-3.358-3.532-1.905-9.276-0.51-0.51
Net Income Ratio 00000-5.20800000000000000000000000
EPS -0.73-0.65-0.63-0.56-0.51-0.47-0.37-0.37-0.45-0.51-0.38-0.44-0.45-0.49-0.45-0.55-0.51-0.4-0.36-0.35-0.33-0.22-0.21-0.23-0.61-0.52-0.64-0.22-0.22
EPS Diluted -0.73-0.65-0.62-0.56-0.51-0.47-0.37-0.37-0.42-0.51-0.38-0.44-0.45-0.49-0.45-0.45-0.41-0.4-0.36-0.35-0.33-0.22-0.21-0.23-0.61-0.52-0.64-0.22-0.22
EBITDA -37.136-23.292-32.622-29.853-27.638-22.81-18.313-15.52-16.591-15.944-11.415-12.822-12.78-13.659-11.342-10.983-9.596-9.22-8.326-8.114-7.819-5.809-4.999-3.781-3.99-2.065-3.0800
EBITDA Ratio 00000-5.68800000000000000000000000